Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE
Effectiveness and Cost-effectiveness of a Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With Systemic Lupus Erythematosus
1 other identifier
interventional
237
1 country
1
Brief Summary
Principal objective: To produce scientific knowledge on the effectiveness and cost-effectiveness of a multicomponent intervention for knowledge transfer and implementing a Clinical Practice Guideline (CPG) for Systemic Lupus Erythematosus (SLE), formed by an educative intervention, an computerized clinical decision support system (SADC), complemented by an automated feedback built into the electronic clinical record. Secondary objectives will be previously developed: 1) the analysis of medical practice variations along the care of SLE patients in the Canary Islands Health Service (SCS); 2) the best available scientific evidence to support the optimal development of the SADC; 3) the context and the barriers to innovation implementation in the SCS; and 4) the development of the contents for the implementation strategy, including the SADC and the automated feedback. Methods for the main objective: The main objective will be assessed under an open, multicentric and randomized (by clusters) clinical trial, in the SCS. The multicomponent intervention will be compared to the usual procedures for CPG dissemination. The main measure will be the self-perceived activity of SLE rated by the SLAQ scale. Self-perceived health related quality of life (HRQoL) data will be obtained by means of the questionnaire EQ-5D-5L , to estimate a cost-effectiveness ratio. Methods for secondary objectives: The rest of the objectives will be developed by a mix of quantitative and qualitative research methods to allow adapting the design, development and execution of the intervention to the characteristics of the context.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2018
CompletedStudy Start
First participant enrolled
April 16, 2018
CompletedFirst Posted
Study publicly available on registry
May 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedSeptember 22, 2021
October 1, 2020
2.5 years
April 16, 2018
September 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of self-perceived activity of the SLE
Disease activity self-reported by the patient using the Systemic Lupus Erythematosus Activity (SLAQ) Questionnaire
18 months
Secondary Outcomes (6)
Change in professional's knowledge about SLE management
18 months
Change in self-perceived health-related quality of life
18 months
Change in self-perceived health-related quality of life
18 months
Patient's perception of their participation in decision making
18 months
Professional's attitude to partnership with the patient for shared decision making
18 months
- +1 more secondary outcomes
Study Arms (2)
Multicomponent Intervention
EXPERIMENTALRheumatologist and internist receive a multicomponent intervention
Control
NO INTERVENTIONRheumatologist and internist provide the usual care
Interventions
Intervention to rheumatologist and internist responsible for the care of patients with SLE. Implementation multicomponent intervention consisting of: educational component, a computerized clinical decision support system developed from the clinical practice guide - SLE and automated feedback integrated into the electronic medical record system.
Eligibility Criteria
You may qualify if:
- Patients:
- Adults (older than 18 years) diagnosed with SLE of any seriousness and situation (active, remission or clinically quiescent and serologically active), who agree to participate and sign informed consent.
- Health professionals:
- Physicians specialized in rheumatology or internal medicine that include in their quotas a minimum of 30 patients with eligible SLE.
You may not qualify if:
- Patients:
- SLE limited to the skin, advanced chronic kidney disease (dialysis or renal transplant); Mental illnesses and / or sensory or cognitive deficits; or participating in extension or follow-up studies of another RCT (possible change in follow-up guidelines). Participants in observational studies may be included as they do not change usual practice.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Servicio Canario de Saludlead
- Instituto de Salud Carlos IIIcollaborator
Study Sites (1)
Servicio de EvaluaciĂ³n del Servicio Canario de la Salud
Santa Cruz de Tenerife, 38004, Spain
Related Publications (29)
Serrano-Aguilar P, Kovacs FM, Cabrera-Hernandez JM, Ramos-Goni JM, Garcia-Perez L. Avoidable costs of physical treatments for chronic back, neck and shoulder pain within the Spanish National Health Service: a cross-sectional study. BMC Musculoskelet Disord. 2011 Dec 21;12:287. doi: 10.1186/1471-2474-12-287.
PMID: 22188790BACKGROUNDOstbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005 May-Jun;3(3):209-14. doi: 10.1370/afm.310.
PMID: 15928223BACKGROUNDZhu TY, Tam LS, Li EK. Cost-of-illness studies in systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken). 2011 May;63(5):751-60. doi: 10.1002/acr.20410.
PMID: 21557530BACKGROUNDLerang K, Gilboe IM, Gran JT. Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus. Rheumatology (Oxford). 2012 Apr;51(4):663-9. doi: 10.1093/rheumatology/ker318. Epub 2011 Dec 7.
PMID: 22157467BACKGROUNDBertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT; Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008 Feb;67(2):195-205. doi: 10.1136/ard.2007.070367. Epub 2007 May 15.
PMID: 17504841BACKGROUNDSidorenkov G, Haaijer-Ruskamp FM, de Zeeuw D, Denig P. A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness. PLoS One. 2011;6(9):e24278. doi: 10.1371/journal.pone.0024278. Epub 2011 Sep 8.
PMID: 21931669BACKGROUNDPerez X, Wisnivesky JP, Lurslurchachai L, Kleinman LC, Kronish IM. Barriers to adherence to COPD guidelines among primary care providers. Respir Med. 2012 Mar;106(3):374-81. doi: 10.1016/j.rmed.2011.09.010. Epub 2011 Oct 13.
PMID: 22000501BACKGROUNDKastner M, Bhattacharyya O, Hayden L, Makarski J, Estey E, Durocher L, Chatterjee A, Perrier L, Graham ID, Straus SE, Zwarenstein M, Brouwers M. Guideline uptake is influenced by six implementability domains for creating and communicating guidelines: a realist review. J Clin Epidemiol. 2015 May;68(5):498-509. doi: 10.1016/j.jclinepi.2014.12.013. Epub 2015 Jan 10.
PMID: 25684154BACKGROUNDCabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999 Oct 20;282(15):1458-65. doi: 10.1001/jama.282.15.1458.
PMID: 10535437BACKGROUNDJacobs SR, Weiner BJ, Bunger AC. Context matters: measuring implementation climate among individuals and groups. Implement Sci. 2014 Apr 17;9:46. doi: 10.1186/1748-5908-9-46.
PMID: 24742308BACKGROUNDFrancke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008 Sep 12;8:38. doi: 10.1186/1472-6947-8-38.
PMID: 18789150BACKGROUNDGrimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci. 2012 May 31;7:50. doi: 10.1186/1748-5908-7-50.
PMID: 22651257BACKGROUNDSketris IS, Langille Ingram EM, Lummis HL. Strategic opportunities for effective optimal prescribing and medication management. Can J Clin Pharmacol. 2009 Winter;16(1):e103-25. Epub 2009 Jan 30.
PMID: 19182305BACKGROUNDGiguere A, Legare F, Grimshaw J, Turcotte S, Fiander M, Grudniewicz A, Makosso-Kallyth S, Wolf FM, Farmer AP, Gagnon MP. Printed educational materials: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD004398. doi: 10.1002/14651858.CD004398.pub3.
PMID: 23076904BACKGROUNDShojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD001096. doi: 10.1002/14651858.CD001096.pub2.
PMID: 19588323BACKGROUNDBaker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, Robertson N. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005470. doi: 10.1002/14651858.CD005470.pub2.
PMID: 20238340BACKGROUNDGillaizeau F, Chan E, Trinquart L, Colombet I, Walton RT, Rege-Walther M, Burnand B, Durieux P. Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev. 2013 Nov 12;2013(11):CD002894. doi: 10.1002/14651858.CD002894.pub3.
PMID: 24218045BACKGROUNDMurphy EV. Clinical decision support: effectiveness in improving quality processes and clinical outcomes and factors that may influence success. Yale J Biol Med. 2014 Jun 6;87(2):187-97. eCollection 2014 Jun.
PMID: 24910564BACKGROUNDRamallo-Farina Y, Garcia-Perez L, Castilla-Rodriguez I, Perestelo-Perez L, Wagner AM, de Pablos-Velasco P, Dominguez AC, Cortes MB, Vallejo-Torres L, Ramirez ME, Martin PP, Garcia-Puente I, Salinero-Fort MA, Serrano-Aguilar PG; INDICA team. Effectiveness and cost-effectiveness of knowledge transfer and behavior modification interventions in type 2 diabetes mellitus patients--the INDICA study: a cluster randomized controlled trial. Implement Sci. 2015 Apr 9;10:47. doi: 10.1186/s13012-015-0233-1.
PMID: 25880498BACKGROUNDRoshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, Handler SM, Nieuwlaat R, Souza NM, Beyene J, Van Spall HG, Garg AX, Haynes RB. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ. 2013 Feb 14;346:f657. doi: 10.1136/bmj.f657.
PMID: 23412440BACKGROUNDLobach D, Sanders GD, Bright TJ, Wong A, Dhurjati R, Bristow E, Bastian L, Coeytaux R, Samsa G, Hasselblad V, Williams JW, Wing L, Musty M, Kendrick AS. Enabling health care decisionmaking through clinical decision support and knowledge management. Evid Rep Technol Assess (Full Rep). 2012 Apr;(203):1-784.
PMID: 23126650BACKGROUNDHoffmann TC, Montori VM, Del Mar C. The connection between evidence-based medicine and shared decision making. JAMA. 2014 Oct 1;312(13):1295-6. doi: 10.1001/jama.2014.10186. No abstract available.
PMID: 25268434BACKGROUNDElwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012 Oct;27(10):1361-7. doi: 10.1007/s11606-012-2077-6. Epub 2012 May 23.
PMID: 22618581BACKGROUNDSerrano-Aguilar P, Trujillo-Martin Mdel M, Perez de la Rosa A, Cuellar-Pompa L, Saavedra-Medina H, Linertova R, Perestelo-Perez L, Perez-Ramos J, Rivero-Santana A; Spanish SLE CPG Development Group. Patient participation in a Clinical Guideline Development for Systemic Lupus Erythematosus. Patient Educ Couns. 2015 Sep;98(9):1156-63. doi: 10.1016/j.pec.2015.05.022. Epub 2015 Jun 11.
PMID: 26095343BACKGROUNDPoliti MC, Wolin KY, Legare F. Implementing clinical practice guidelines about health promotion and disease prevention through shared decision making. J Gen Intern Med. 2013 Jun;28(6):838-44. doi: 10.1007/s11606-012-2321-0. Epub 2013 Jan 10.
PMID: 23307397BACKGROUNDLoya SR, Kawamoto K, Chatwin C, Huser V. Service oriented architecture for clinical decision support: a systematic review and future directions. J Med Syst. 2014 Dec;38(12):140. doi: 10.1007/s10916-014-0140-z. Epub 2014 Oct 18.
PMID: 25325996BACKGROUNDPanzarasa S, et al.Technical Solutions for Integrating Clinical Practice Guidelines with Electronic Patient Records. Volume 5943 of LNAI. Springer-Verlag 2010;141 -154
BACKGROUNDKawamoto K, Del Fiol G, Orton C, Lobach DF. System-agnostic clinical decision support services: benefits and challenges for scalable decision support. Open Med Inform J. 2010;4:245-54. doi: 10.2174/1874431101004010245. Epub 2010 Dec 14.
PMID: 21603281BACKGROUNDTrujillo-Martin MM, Ramallo-Farina Y, Del Pino-Sedeno T, Rua-Figueroa I, Trujillo-Martin E, Vallejo-Torres L, Imaz-Iglesia I, Sanchez-de-Madariaga R, de Pascual-Medina AM, Serrano-Aguilar P; SLE-CPG-Implementation Group. Effectiveness and cost-effectiveness of a multicomponent intervention to implement a clinical practice guideline for systemic lupus erythematosus: protocol for a cluster-randomized controlled trial. BMC Health Serv Res. 2019 Nov 1;19(1):783. doi: 10.1186/s12913-019-4589-9.
PMID: 31675957DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MarĂa de Mar Trujillo Martin, PhD
Servicio de EvaluaciĂ³n del Servicio Canario de la Salud
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2018
First Posted
May 25, 2018
Study Start
April 16, 2018
Primary Completion
October 19, 2020
Study Completion
December 31, 2020
Last Updated
September 22, 2021
Record last verified: 2020-10